Anus Laboratories Delisted Share Price

Anus Laboratories Limited Incoporation Details

Anus Laboratories Limited CIN Number	L24230TG1996PLC023283
Anus Laboratories Limited Date of Incorporation	20-Feb-96
Category / Sub-Category of Anus Laboratories Limited	Public Limited Company
Anus Laboratories Limited Registered Office Address	H.NO. A-49MADHURANAGAR YOUSUFGUDA HYDERABAD, A.P. TG 500038 IN .
Anus Laboratories Limited Registrar & Transfer Agent Address and Contact Details	KFIN Technologies Pvt. Ltd. Plot No. 17-24, Vittal Rao Nagar, Madhapur, Hyderabad - 500081 Telangana

FAQs on Anus Laboratories Ltd 

Q: What is the face value of Anus Laboratories Ltd shares?
Answer: The face value of Anus Laboratories Ltd is ₹1 per equity share.

Q: How can I buy Anus Laboratories unlisted shares through WWIPL?
Answer: Investors can complete the KYC process, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy Anus Laboratories shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in Anus Laboratories Ltd a good idea?
Answer: Investors often evaluate Anus Laboratories based on its pharmaceutical manufacturing capabilities, financial performance, valuation, and long-term growth potential in the healthcare sector.

Q: Why do investors buy Anus Laboratories shares before a potential IPO?
Answer: Investors seek early exposure to an unlisted pharmaceutical company with the expectation of long-term value creation and potential liquidity through a future listing.

Q: What business does Anus Laboratories Ltd operate in?
Answer: According to WWIPL, Anus Laboratories operates in the Pharmaceuticals sector and is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and related products.

Q: Who founded Anus Laboratories Ltd?
Answer: Anus Laboratories Ltd was incorporated as a public limited company and operates in the pharmaceutical manufacturing industry.

Q: What makes Anus Laboratories different from other unlisted pharmaceutical companies?
Answer: The company provides investors with exposure to the pharmaceutical manufacturing value chain through its focus on APIs and pharmaceutical intermediates.

Q: What are the key growth drivers for Anus Laboratories Ltd?
Answer: Rising healthcare demand, increasing pharmaceutical exports, growth in API manufacturing, regulatory compliance, capacity expansion, and product diversification are key growth drivers.

Q: What factors affect the valuation of Anus Laboratories shares?
Answer: Revenue growth, manufacturing capacity, profitability, regulatory approvals, export performance, market demand for unlisted shares, and future listing prospects are important valuation drivers.

Q: Are Anus Laboratories shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my Anus Laboratories shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and share availability.

Q: What documents are required to buy Anus Laboratories shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in Anus Laboratories shares?
Answer: Investors should consider regulatory compliance risks, pricing pressure, raw material availability, competition, product concentration, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track Anus Laboratories investments?
Answer: WWIPL provides company updates, transaction assistance, market information, and investment insights to help investors stay informed.

Q: How long does it take for Anus Laboratories shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Anus Laboratories Ltd?
Answer: Investors should assess the company's manufacturing capabilities, regulatory compliance, financial performance, profitability, valuation, and long-term growth prospects.

Q: Can Anus Laboratories benefit from India's growing pharmaceutical industry?
Answer: Yes. Rising global demand for APIs, increasing pharmaceutical exports, expanding healthcare spending, and government support for domestic drug manufacturing may create significant long-term growth opportunities for the company.